Condition: Acute Lymphoblastic Leukemia · Relapsed Pediatric ALL · Refractory Acute Lymphoblastic Leukemia · Sponsor: Chongqing Precision Biotech Co., Ltd
This is a phase II clinical study to evaluate the safety and efficacy of pCAR-19 B cell autologous infusion preparation in the treatment of CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia.
This description comes directly from the study's public registry record.
Tianyou Wang, M.D · 010-59616161 · wangtianyou@bch.com.cn
Yicheng Zhang, M.D · 18607140317 · yczhang@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
| Beijing Children's Hospital.Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Beijing GoBroad Boren Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Xiehe Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| The Second Xiangya Hospital, Central South University | Changsha, Hunan, China | Recruiting |
| Children's Hospital Of Soochow University | Suzhou, Jiangsu, China | Recruiting |
| The First Affiliated Hospital Of Nanchang University | Nanchang, Jiangxi, China | Recruiting |
| West China Second University Hospital,Sichuan University | Chengdu, Sichuan, China | Recruiting |
| Institute Of Hematology&Blood Diseases Hospital,Chinese Academy Of Medicai Sciences | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05334823